Updated FAQ: long-acting injectable buprenorphine funding program

Washington State Health Care Authority sent this bulletin at 12/20/2024 08:00 AM PST

December 20, 2024

Can’t access the links? Add “lnks.gd” to the allowlist of your content blocking software.

Long-acting injectable (LAI) buprenorphine funding program FAQ update

The frequently asked questions (FAQ) document for the LAI funding program has been updated based on feedback from providers.

About the LAI buprenorphine funding program

The Washington State Legislature appropriated $3 million of the opioid abatement settlement to the Health Care Authority (HCA) to increase access to LAI buprenorphine products. HCA must use these funds to:

Provide LAI buprenorphine products to small providers that are not financially affiliated with a hospital, nor will any provider administer the medications received through this program to a patient in a carceral facility; and
Cover the cost and administration of the drug for uninsured individuals that do not qualify for other state or federal health insurance programs.

This program ends on June 30, 2025, or when funding is exhausted, whichever occurs first.

View updated FAQ

About the Health Care Authority (HCA)

Functioning as both the state's largest health care purchaser and its behavioral health authority, the Washington State Health Care Authority (HCA) is a leader in ensuring Washington residents have the opportunity to be as healthy as possible.

There are three pillars of our work: Apple Health (Medicaid); the Public Employees Benefits Board (PEBB) and School Employees Benefits Board (SEBB) programs; and behavioral health and recovery. Under these pillars, HCA purchases health care, including behavioral health treatment for more than 2.7 million Washington residents and provides behavioral health prevention, crisis, and recovery supports to all Washington residents.

Please do not reply directly to this message. For more information, visit the HCA website, where you'll also find contact information.

Disclosure notice

All messages we send via GovDelivery are subject to public disclosure, as are the names and email addresses of those who sign up for email notifications.

Nondiscrimination

The Washington State Health Care Authority (HCA) complies with all applicable federal and Washington state civil rights laws and is committed to providing equal access to our services. Visit HCA’s website to view complete nondiscrimination statements.